QR Code

Efficacy and Safety of IncobotulinumtoxinA for the Treatment of Blepharospasm: A Multicenter, Phase 3 Study in Japan

This open-label, uncontrolled, single-arm, multicenter, phase 3 study evaluated the efficacy and safety of incobotulinumtoxinA in Japanese patients with blepharospasm. Eligible patients received incobotulinumtoxinA injections at fixed doses (50, 75, or 100 units [U] for those who had previously rece...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Toshiaki Goseki, Yoshihito Mochizuki, Akiko Masuda, Motohiro Kiyosawa, Ryosuke Miyamoto, Masato Wakakura, Akiko Yamagami, Yohei Mukai, Akihiro Shinkai, Mutsumi Iijima, Kousuke Baba, Hideki Chuman, Masahiro Hashizuka, Shohei Tateishi, Akiko Kimura
Hōputu: Artigo
Reo:Inglês
I whakaputaina: MDPI AG 2026-02-01
Rangatū:Toxins
Ngā marau:
blepharospasm
botulinum toxin
dystonia
East Asia
efficacy
incobotulinumtoxinA
Urunga tuihono:https://www.mdpi.com/2072-6651/18/2/109
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite